The development of autoantibodies was positively associated with the development of irAEs, but did not reach statistical significance (OR 2.92; 95% CI 0.85 to 10.01).
← all excerpts
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity.
1
—
—